Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111606811B reveals a solvent-free, high-yield route for terbinafine hydrochloride. Discover cost-effective manufacturing and reliable supply chain solutions.
Novel selenium-bridged ruthenium carborane synthesis patent CN103739627B offers high purity and scalable routes for boron-rich pharmaceutical intermediates ensuring supply chain stability.
Patent CN104017001A reveals improved moxidectin synthesis. Reduces cost and improves supply chain reliability for veterinary drug manufacturers.
Patent CN111574523A reveals a novel one-step synthesis for 1'-substituted carbon nucleoside analogs, offering significant cost reduction and supply chain reliability for antiviral drug manufacturers.
Novel BF3-MeCN catalyzed route for Cefoperazone Acid production. High purity, simplified steps, and cost-effective manufacturing capabilities for global pharmaceutical supply chains.
Patent CN115353519A reveals a novel IBX oxidation route for BTK inhibitor intermediates, offering >99.5% purity and eliminating costly column chromatography for scalable manufacturing.
Patent CN101081851B reveals a high-yield 4-step synthesis for alpha-azaspiro templates. Discover cost-effective manufacturing and scalable supply chain solutions.
Novel sodium tert-butoxide catalyzed route offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing and significant cost efficiency gains.
Novel patent CN104151220A enables cost-effective production of N,N'-dialkyl dithiooxamide. Enhanced supply chain reliability and purity for pharma and agrochemical applications.
Patent CN105541773A details a green synthesis route for 3,4-dihydro-4-arylcoumarins using recyclable catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN116023285A details a one-pot method for 3-ethoxy-4-trimethylammonio-2-butenoic acid salt, ensuring reliable high-purity reference standards.
Patent CN102603591B details a novel route for Vernakalant intermediates. Offers mild conditions, high optical purity, and scalable supply chain solutions for global procurement.
Novel patent CN119504617A offers high-yield Suvorexant intermediate preparation. Reduces cost and improves purity for pharmaceutical supply chains.
Novel synthetic route for Elacestrant improves yield and purity while reducing hazardous reagent use for reliable supply chain continuity.
Patent CN111943959A reveals a novel convergent synthesis for JAK inhibitors. Discover cost-effective manufacturing strategies and high-purity intermediate supply solutions.
Novel enzymatic synthesis route for HIV integrase inhibitor intermediates. High purity, scalable process offering significant supply chain stability and cost efficiency for pharmaceutical partners.
Patent CN110759929B details a non-toxic CrO3 oxidation route for (5R)-5-hydroxy triptolide, offering superior yield and eliminating selenium waste for reliable supply.
Novel enzymatic synthesis route ensures high purity and yield for HIV integrase inhibitor intermediates, offering significant supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Novel iridium-catalyzed route for amino-(N-alkyl) benzene sulfonamide offers high atom economy and green manufacturing advantages for pharmaceutical supply chains.
Patent CN118388570A reveals a novel enzymatic-chemical hybrid route for UDCA intermediates. Achieve superior selectivity and safety for pharmaceutical manufacturing.